Fikri İçlı

1.3k total citations
76 papers, 989 citations indexed

About

Fikri İçlı is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Fikri İçlı has authored 76 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Fikri İçlı's work include Cancer Treatment and Pharmacology (11 papers), Lymphoma Diagnosis and Treatment (10 papers) and Gastric Cancer Management and Outcomes (7 papers). Fikri İçlı is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), Lymphoma Diagnosis and Treatment (10 papers) and Gastric Cancer Management and Outcomes (7 papers). Fikri İçlı collaborates with scholars based in Türkiye, United States and Iran. Fikri İçlı's co-authors include Hakan Akbulut, Dìlek Dìnçol, Abdullah Büyükçelik, Ahmet Demirkazık, Ahmet Demirkazık, Ömer Küçük, Taner Demirer, Özden Uzunalımoǧlu, Bülent Yalçın and K. Gonca Akbulut and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Fikri İçlı

74 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fikri İçlı Türkiye 17 404 266 183 182 169 76 989
DJ Kerr United Kingdom 20 598 1.5× 188 0.7× 299 1.6× 223 1.2× 179 1.1× 53 1.2k
Sabri Barutça Türkiye 16 268 0.7× 204 0.8× 115 0.6× 118 0.6× 77 0.5× 60 774
Anna Balcerska Poland 18 271 0.7× 171 0.6× 227 1.2× 330 1.8× 122 0.7× 137 1.5k
Banu Öztürk Türkiye 19 244 0.6× 223 0.8× 92 0.5× 226 1.2× 95 0.6× 118 1.2k
Marie Robert France 20 402 1.0× 210 0.8× 171 0.9× 226 1.2× 68 0.4× 78 1.3k
Daisy Saw China 18 479 1.2× 151 0.6× 279 1.5× 208 1.1× 203 1.2× 37 1.0k
Hiroshi Osawa Japan 19 124 0.3× 210 0.8× 205 1.1× 241 1.3× 120 0.7× 120 1.2k
Andrew Eisenberger United States 17 288 0.7× 165 0.6× 158 0.9× 333 1.8× 128 0.8× 51 1.2k
A. Carbone Italy 20 327 0.8× 143 0.5× 233 1.3× 273 1.5× 70 0.4× 96 1.2k
CS McArdle United Kingdom 20 458 1.1× 193 0.7× 331 1.8× 170 0.9× 166 1.0× 52 1.1k

Countries citing papers authored by Fikri İçlı

Since Specialization
Citations

This map shows the geographic impact of Fikri İçlı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fikri İçlı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fikri İçlı more than expected).

Fields of papers citing papers by Fikri İçlı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fikri İçlı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fikri İçlı. The network helps show where Fikri İçlı may publish in the future.

Co-authorship network of co-authors of Fikri İçlı

This figure shows the co-authorship network connecting the top 25 collaborators of Fikri İçlı. A scholar is included among the top collaborators of Fikri İçlı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fikri İçlı. Fikri İçlı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yazıcı, Ozan, Mutlu Doğan, Ahmet Demirkazık, et al.. (2020). Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer. Combinatorial Chemistry & High Throughput Screening. 24(8). 1229–1235. 6 indexed citations
2.
Zengin, Nurullah, et al.. (2017). A new angiogenesis prognostic index with VEGFA, PlGF, and angiopoietin1 predicts survival in patients with advanced gastric cancer. TURKISH JOURNAL OF MEDICAL SCIENCES. 47(2). 399–406. 12 indexed citations
3.
Eralp, Yeşim, Leyla Kılıç, Gül Alço, et al.. (2014). The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience. SHILAP Revista de lepidopterología. 10(4). 209–215. 5 indexed citations
4.
Doğan, Mutlu, Güngör Utkan, Doğan Uncu, et al.. (2014). The clinicopathological characteristics with long-term outcomes in malignant mesothelioma. Medical Oncology. 31(10). 232–232. 4 indexed citations
5.
İçlı, Fikri, et al.. (2013). Fighting Against Cigarette Smoking Among Medical Students: A Success Story. Journal of Cancer Education. 29(3). 458–462. 5 indexed citations
6.
Doğan, Mutlu, Halil Gürhan Karabulut, Ajlan Tükün, et al.. (2012). Relationship Between Antimetabolite Toxicity and Pharmacogenetics in Turkish Cancer Patients. Asian Pacific Journal of Cancer Prevention. 13(4). 1553–1556. 8 indexed citations
7.
Ürün, Yüksel, Nuriye Özdemir, Güngör Utkan, et al.. (2012). ABO and Rh Blood Groups and Risk of Colorectal Adenocarcinoma. Asian Pacific Journal of Cancer Prevention. 13(12). 6097–6100. 23 indexed citations
8.
Doğan, Mutlu, et al.. (2010). Intestinal malignant melanoma presenting with small bowel invagination: A case report. The Turkish Journal of Gastroenterology. 21(4). 439–442. 5 indexed citations
9.
İçlı, Fikri, Hakan Akbulut, Shouki Bazarbashi, et al.. (2010). Modification and Implementation of NCCN Guidelines™ on Colon Cancer in the Middle East and North Africa Region. Journal of the National Comprehensive Cancer Network. 8(Suppl 3). S–22. 2 indexed citations
10.
Dìnçol, Dìlek, Abdullah Büyükçelik, Mutlu Doğan, et al.. (2009). Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP. Medical Oncology. 27(3). 942–945. 3 indexed citations
11.
İçlı, Fikri, Hakan Akbulut, Güngör Utkan, et al.. (2006). Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer. Journal of Surgical Oncology. 95(6). 507–512. 84 indexed citations
12.
Emri, Salih, Hakan Akbulut, Faruk Zorlu, et al.. (2001). Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma. Lung Cancer. 33(2-3). 109–114. 16 indexed citations
13.
Dìnçol, Dìlek, Hakan Akbulut, Abdullah Büyükçelik, & Fikri İçlı. (2000). DIURNAL VARIATIONS OF SERUM GM-CSF LEVELS. Cytokine. 12(7). 1151–1155. 10 indexed citations
14.
Ekinci, Cemil, et al.. (2000). Cytology of Clear Cell Carcinoma of the Female Genital Tract in Fine Needle Aspirates and Ascites. Acta Cytologica. 44(6). 1005–1009. 12 indexed citations
15.
16.
İçlı, Fikri, et al.. (1997). Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer. Journal of Surgical Oncology. 64(4). 318–323. 3 indexed citations
17.
İçlı, Fikri, et al.. (1996). Two dose levels of ifosfamide in malignant mesothelioma. Lung Cancer. 15(2). 207–213. 14 indexed citations
18.
İçlı, Fikri, et al.. (1993). Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer. 72(2). 587–593. 107 indexed citations
19.
İçlı, Fikri, et al.. (1991). Treatment of metastatic malignant melanoma with 24 hours continuous venous infusion of dacarbazine and cisplatin. Journal of Surgical Oncology. 48(3). 199–201. 3 indexed citations
20.
İçlı, Fikri, et al.. (1986). Basal cell carcinoma with lung metastases: A case report. Journal of Surgical Oncology. 33(1). 57–60. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by DJ Kerr Breakdown of academic impact, for papers by Sabri Barutça Breakdown of academic impact, for papers by Anna Balcerska Breakdown of academic impact, for papers by Banu Öztürk Breakdown of academic impact, for papers by Marie Robert Breakdown of academic impact, for papers by Daisy Saw Breakdown of academic impact, for papers by Hiroshi Osawa Breakdown of academic impact, for papers by Andrew Eisenberger Breakdown of academic impact, for papers by A. Carbone Breakdown of academic impact, for papers by CS McArdle
Rankless by CCL
2026